We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Economic Barriers in the Treatment of Clostridium difficile Infection With Oral Vancomycin.
- Authors
Bunnell, Kristen L.; Danziger, Larry H.; Johnson, Stuart
- Abstract
Vancomycin is an increasingly important option for the treatment of Clostridium difficile infection, but economic barriers to its use remain significant in the outpatient setting. Generic vancomycin capsules are still inexplicably expensive and not universally covered by insurers. This report highlights the potential adverse consequences of cost-related nonadherence to vancomycin therapy and the challenges that clinicians face when prescribing oral vancomycin.
- Subjects
CLOSTRIDIOIDES difficile; VANCOMYCIN; MEDICAL care costs; THERAPEUTICS
- Publication
Open Forum Infectious Diseases, 2017, Vol 4, Issue 2, p1
- ISSN
2328-8957
- Publication type
Article
- DOI
10.1093/ofid/ofx078